The British firm that says it has created an erection sustaining condom has fallen out with its marketing partner, Reckitt Benckiser, forcing it to go ahead with production on its own.
Futura Medical says it was unable to find: "common ground acceptable to both parties in respect of their continued development and commercialisation of the CSD500 condom."
Surrey based Futura now says it will take control of the manufacturing process on its own while it casts around for other potential partners.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group's Chief Executive, James Barder, said: "Futura has received considerable interest in CSD500 from potential marketing partners. We are therefore confident of relicensing the product on attractive commercial terms and of creating significant value for shareholders."
The market was less than happy with the news. Futura's stock is down 19% at 11:31.
BS
-
Saba Capital and Boaz Weinstein respond to investment trustsAs investment trust managers and industry experts accuse Saba of self-motivated opportunism, the hedge fund responds to specific "misleading claims" and sets out its stall
-
How to find top-quality companies with growing dividendsIan Mortimer, portfolio manager of Guinness Global Equity Income Fund, shares where he would put his money for sustainable and growing dividends
